EP 0587749 A4 19950830 - COMPOSITIONS AND DELIVERY SYSTEMS FOR TRANSDERMAL ADMINISTRATION OF NEUTRAL OLIGOMERS
Title (en)
COMPOSITIONS AND DELIVERY SYSTEMS FOR TRANSDERMAL ADMINISTRATION OF NEUTRAL OLIGOMERS
Publication
Application
Priority
US 70787991 A 19910531
Abstract (en)
[origin: WO9221353A1] Neutral Oligomers may be delivered transdermally and across mucous membranes for therapeutic purposes, such as to block expression of a specific target nucleic acid sequence. These neutral Oligomers are useful in treating a variety of pathological conditions, including those of the skin and mucous membranes, as well as conditions effecting other tissues.
IPC 1-7
IPC 8 full level
A61K 31/70 (2006.01); A61K 8/55 (2006.01); A61K 47/48 (2006.01); A61K 48/00 (2006.01); A61P 9/12 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); A61Q 7/00 (2006.01); C07H 21/00 (2006.01); C12N 15/113 (2010.01)
CPC (source: EP)
A61K 8/55 (2013.01); A61K 31/70 (2013.01); A61K 47/50 (2017.07); A61P 9/12 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); A61Q 7/00 (2013.01); C07H 21/00 (2013.01); C12N 15/113 (2013.01); C12N 2310/3125 (2013.01)
Citation (search report)
- [XY] WO 8906702 A1 19890727 - CHEMEX PHARMACEUTICALS INC [US]
- [X] WO 9106626 A2 19910516 - GILEAD SCIENCES INC [US]
- [DY] WO 8703473 A1 19870618 - HSIEH DEAN
- [Y] MILLER, P.: "Oligonucleoside methylphosphonates as antisense reagents", BIOTECHNOLOGY, vol. 9, no. 4, 1991, NEW YORK US, pages 358 - 362
- See references of WO 9221353A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
DOCDB simple family (publication)
WO 9221353 A1 19921210; AU 2169992 A 19930108; CA 2110040 A1 19921210; EP 0587749 A1 19940323; EP 0587749 A4 19950830; IE 921773 A1 19921202; IL 101978 A0 19921230; JP H06507911 A 19940908
DOCDB simple family (application)
US 9204370 W 19920522; AU 2169992 A 19920522; CA 2110040 A 19920522; EP 92913290 A 19920522; IE 921773 A 19920701; IL 10197892 A 19920522; JP 50049093 A 19920522